Novavax is the latest coronavirus-vaccine developer to advance its testing, saying its candidate started a Phase 2 trial in South Africa
Novavax Inc. said Monday its experimental Covid-19 vaccine is starting the second phase of testing to see if it can safely protect against the new coronavirus.
The vaccine candidate is the latest to move a crucial step closer to wide use, behind a handful of shots that have already started the final stage of testing and one developed in Russia that the government there cleared after limited study.The company’s so-called Phase 2b trial will take place in South Africa, which is among the countries hit hardest by coronavirus, with more than 587,000 cases and over 11,800 deaths, according to data from Johns Hopkins University.
“Because South Africa is experiencing a winter surge of Covid-19 disease, this important Phase 2b clinical trial has the potential to provide an early indication of efficacy, along with additional” data about the candidate’s safety and the immune response it generates, said Dr. Gregory Glenn, Novavax’s president of research and development.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19 vaccine trial volunteers stream into hotspot FloridaPhase three of Moderna's vaccine clinical trials, in which thousands of people take part in the final stages, are gaining traction in Florida, the new US epicentre of the global health crisis.
Read more »
Inside the multibillion dollar race for a Covid-19 vaccineThe world is betting on one thing to stop the pandemic: A vaccine. This is what it will take to bring one to the masses — and the key players behind those efforts.
Read more »
Inside the multibillion dollar race for a Covid-19 vaccineThe world is betting on one thing to stop the pandemic: A vaccine. This is what it will take to bring one to the masses — and the key players behind those efforts.
Read more »
Modi says India set to mass produce COVID-19 vaccine, launches digital health missionIndia is ready to mass produce COVID-19 vaccines when scientists give the go-ahead, Prime Minister Narendra Modi said in his Independence Day speech on Saturday, also launching a national project to roll out health identities for each citizen.
Read more »
Russia produces first batch of COVID-19 vaccine: InterfaxRussia has produced the first batch of its new vaccine for COVID-19, the Interfax news agency quoted the health ministry as saying on Saturday, hours after the ministry reported the start of manufacturing.
Read more »
Inside the multibillion dollar race for a Covid-19 vaccineThe world is betting on one thing to stop the pandemic: A vaccine. This is what it will take to bring one to the masses — and the key players behind those efforts.
Read more »